Mortality in Tonga over three triennia, 2010-2018.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
06 01 2021
Historique:
received: 05 09 2020
accepted: 08 12 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Tonga is a South Pacific Island country with a population of 100,651 (2016 Census). This study examines Tongan infant mortality rates (IMR), under-five mortality rates (U5MR), adult mortality and life expectancy (LE) at birth from 2010 to 2018 using a recent collation of empirical mortality data over the past decade for comparison with other previously published mortality estimates. Routinely collected mortality data for 2010-2018 from the Ministry of Health, national (Vaiola) hospital, community nursing reports, and the Civil Registry, were consolidated by deterministic and probabilistic linkage of individual death records. Completeness of empirical mortality reporting was assessed by capture-recapture analysis. The reconciled data were aggregated into triennia to reduce stochastic variation, and used to estimate IMR and U5MR (per 1000 live births), adult mortality (15-59, 15-34, 35-59, and 15-64 years), and LE at birth, employing the hypothetical cohort method (with statistical testing). Mortality trends and differences were assessed by Poisson regression. Mortality findings were compared with published national and international agency estimates. Over the three triennia in 2010-2018, levels varied minimally for IMR (12-14) and U5MR (15-19) per 1000 births (both ns, p > 0.05), and also for male LE at birth of 64-65 years, and female LE at birth 69-70 years. Cumulated risks of adult mortality were significantly higher in men than women; period mortality increases in 15-59-year women from 18 to 21% were significant (p < 0.05). Estimated completeness of the reconciled data was > 95%. International agencies reported generally comparable estimates of IMR and U5MR, with varying uncertainty intervals; but they reported significantly lower adult mortality and higher LE than the empirical estimates from this study. Life expectancy in Tonga over 2010-2018 has remained relatively low and static, with low IMR and U5MR, indicating the substantial impact from premature adult mortality. This analysis of empirical data (> 95% complete) indicates lower LE and higher premature adult mortality than previously reported by international agencies using indirect and modelled methods. Continued integration of mortality recording and data systems in Tonga is important for improving the completeness and accuracy of mortality estimation for local health monitoring and planning.

Sections du résumé

BACKGROUND
Tonga is a South Pacific Island country with a population of 100,651 (2016 Census). This study examines Tongan infant mortality rates (IMR), under-five mortality rates (U5MR), adult mortality and life expectancy (LE) at birth from 2010 to 2018 using a recent collation of empirical mortality data over the past decade for comparison with other previously published mortality estimates.
METHODS
Routinely collected mortality data for 2010-2018 from the Ministry of Health, national (Vaiola) hospital, community nursing reports, and the Civil Registry, were consolidated by deterministic and probabilistic linkage of individual death records. Completeness of empirical mortality reporting was assessed by capture-recapture analysis. The reconciled data were aggregated into triennia to reduce stochastic variation, and used to estimate IMR and U5MR (per 1000 live births), adult mortality (15-59, 15-34, 35-59, and 15-64 years), and LE at birth, employing the hypothetical cohort method (with statistical testing). Mortality trends and differences were assessed by Poisson regression. Mortality findings were compared with published national and international agency estimates.
RESULTS
Over the three triennia in 2010-2018, levels varied minimally for IMR (12-14) and U5MR (15-19) per 1000 births (both ns, p > 0.05), and also for male LE at birth of 64-65 years, and female LE at birth 69-70 years. Cumulated risks of adult mortality were significantly higher in men than women; period mortality increases in 15-59-year women from 18 to 21% were significant (p < 0.05). Estimated completeness of the reconciled data was > 95%. International agencies reported generally comparable estimates of IMR and U5MR, with varying uncertainty intervals; but they reported significantly lower adult mortality and higher LE than the empirical estimates from this study.
CONCLUSIONS
Life expectancy in Tonga over 2010-2018 has remained relatively low and static, with low IMR and U5MR, indicating the substantial impact from premature adult mortality. This analysis of empirical data (> 95% complete) indicates lower LE and higher premature adult mortality than previously reported by international agencies using indirect and modelled methods. Continued integration of mortality recording and data systems in Tonga is important for improving the completeness and accuracy of mortality estimation for local health monitoring and planning.

Identifiants

pubmed: 33407295
doi: 10.1186/s12889-020-10023-w
pii: 10.1186/s12889-020-10023-w
pmc: PMC7789386
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Références

BMC Public Health. 2012 Jun 13;12:436
pubmed: 22694936
Aust N Z J Public Health. 2013 Dec;37(6):509-15
pubmed: 24892148
Asia Pac J Public Health. 2016 Sep;28(6):475-85
pubmed: 27122623
Health Inf Manag. 2007 Jul;36(2):43-48
pubmed: 28758499
Asia Pac J Public Health. 2017 Apr;29(3):171-179
pubmed: 28434247
Asia Pac J Public Health. 2011 Jan;23(1):10-23
pubmed: 21169596
Int J Epidemiol. 2005 Feb;34(1):207-14
pubmed: 15465904
Lancet. 2015 Oct 3;386(10001):1395-1406
pubmed: 25971218
Aust N Z J Public Health. 1998 Feb;22(1):27-36
pubmed: 9599849
Popul Health Metr. 2016 Mar 15;14:7
pubmed: 26981050
Epidemiol Rev. 1995;17(2):243-64
pubmed: 8654510
Popul Health Metr. 2012 Aug 14;10(1):14
pubmed: 22891707
Popul Health Metr. 2016 May 23;14:20
pubmed: 27222639
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Popul Health Metr. 2012 Mar 05;10(1):4
pubmed: 22390221
Am J Epidemiol. 1990 Feb;131(2):373-5
pubmed: 2296988
Med J Aust. 2019 May;210(9):403-409
pubmed: 31025719
Aust N Z J Public Health. 1998 Feb;22(1):37-44
pubmed: 9599850
Popul Health Metr. 2016 Feb 29;14:3
pubmed: 26933387
Aust N Z J Public Health. 2011 Oct;35(5):412-20
pubmed: 21973247

Auteurs

Carah Figueroa (C)

School of Population Health, University of New South Wales, UNSW Sydney, Sydney, Australia.

Christine Linhart (C)

School of Population Health, University of New South Wales, UNSW Sydney, Sydney, Australia.

Latu Fusimalohi (L)

Ministry of Health, Nuku'alofa, Tonga.

Sioape Kupu (S)

Ministry of Health, Nuku'alofa, Tonga.

Gloria Mathenge (G)

Statistics for Development Division, Pacific Community, Nouméa, New Caledonia.

Stephen Morrell (S)

School of Population Health, University of New South Wales, UNSW Sydney, Sydney, Australia.

Richard Taylor (R)

School of Population Health, University of New South Wales, UNSW Sydney, Sydney, Australia. r.taylor@unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH